Published in Ocular Surface

CEQUA - An Innovative Treatment Formulation for Dry Eye Disease

This post is sponsored by Sun Ophthalmics
0 min read
Join Marguerite McDonald, MD, and Derek Cunningham, OD, FAAO, as they discuss how CEQUA can be used for your dry eye patients!
CEQUA™ - An Innovative Treatment Formulation for Dry Eye Disease
Derek Cunningham, OD, FAAO
About Derek Cunningham, OD, FAAO

Derek Cunningham, OD, FAAO has conducted advanced research that covers a vast spectrum of eyecare and neuroscience including; dry eye treatments, glaucoma medications and surgeries, retinal disease, cataract and lasik surgeries, cosmetic treatments and products, vision enhancement, and sports vision. His innovative research has been presented at all major meetings ranging from the American Retinal society, the Academies of Ophthalmology and Optometry, to the American College of Sports Medicine. His research has been featured in many medical journals and showcased in publications such as Sports Illustrated and Forbes Magazine.

In addition to having been an associate professor at Texas Tech School of Medicine, Dr. Cunningham also held adjunct professor status at the Inter American University of Puerto Rico and the University of Waterloo, University of Houston, and the University of Incarnate Word.

Dr. Cunningham is an internationally recognized educator, having provided continuing education lectures to eye doctors throughout the world. He is also a Fellow of the American Academy of Optometry and is board certified by the American Board of Optometry. He is also the founding Chair of the Integrated Ophthalmic Task Force for the American Society of Cataract and Refractive Surgery.

Dr. Cunningham is the director of the Dry Eye Institute at Dell Laser Consultants (DLC) and is well-published in the areas of advanced dry eye treatments and facial aesthetics. He has presented to and educated leading ophthalmologists, corneal specialists, and optometrists in the United States and numerous countries around the world. Many of Dr. Cunningham’s dry eye protocols are being used by academic institutions around the country and his eye disease grading scales are even research standards in other countries.

Derek Cunningham, OD, FAAO
Marguerite McDonald, MD
About Marguerite McDonald, MD

Marguerite McDonald, M.D., F.A.C.S., is a board-certified ophthalmologist offering corneal, cataract and refractive surgery. Dr. McDonald is certified on the CATALYS Femtosecond Laser to perform Laser Assisted Cataract Surgery (LACS).

Dr. McDonald is a Clinical Professor of Ophthalmology at NYU School of Medicine and an Adjunct Clinical Professor of Ophthalmology at Tulane University Health Sciences Center in New Orleans. She formerly served as a Professor of Ophthalmology and Director of the Corneal Service at the LSU Eye Center, LSU Medical Center School of Medicine in New Orleans. Dr. McDonald is currently a senior consultant for several medical device companies and was previously the Medical Director for Alcon/Summit/Autonomous.

Dr. McDonald has been the principal investigator of three National Eye Institute grants for the study of refractive surgery. In New Orleans, she headed the research team investigating the use of the excimer laser. In 1987, she performed the world’s first excimer laser treatment, and in 1993, she performed the world’s first excimer laser surgery for farsightedness. Dr. McDonald also served as a principal investigator for Bausch and Lomb and Nidek EC 5000 lasers. As a result, she performed the world’s first Summit/Autonomous wavefront-based excimer laser surgeries. Dr. McDonald was the second physician in the United States and the third physician in the world to perform CK (conductive keratoplasty) for farsightedness. She was the medical monitor of the U.S. clinical trials that led to the FDA approval of CK. Dr. McDonald was also the first North American surgeon to perform Epi-LASIK.

Dr. McDonald received her medical degree from Columbia University College of Physicians and Surgeons. She completed her internship at Lenox Hill Hospital and her ophthalmology residency at Manhattan Eye Ear and Throat Hospital / Cornell. She also underwent fellowship training in corneal and external diseases at the LSU Eye Center in New Orleans, after which she was asked to join the faculty team.

Dr. McDonald has served on the editorial boards of several publications. In 1997, she was elected to the Executive Committee of the prestigious American Society of Cataract and Refractive Surgery (ASCRS). She was elected the first female president of the ASCRS in 2002-2003. Most recently, Dr. McDonald served as the first female president of the International Society of Refractive Surgery.

Marguerite McDonald, MD